Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Extended course accelerated intermittent theta burst stimulation as a substitute for depressed patients needing electroconvulsive therapy
    Published on 2024-10-23
    9 months ago
  • Deep phenotyping reveals CRH and FKBP51-dependent behavioral profiles following chronic social stress exposure in male mice
    Published on 2024-10-22
    9 months ago
  • NPP Editorial: tides of progress
    Published on 2024-10-22
    9 months ago
  • Phytocannabinoids restore seizure-induced alterations in emotional behaviour in male rats
    Published on 2024-10-21
    9 months ago
  • Efficacy and safety of JNJ-42165279, a fatty acid amide hydrolase inhibitor, in adolescents and adults with autism spectrum disorder: a randomized, phase 2, placebo-controlled study
    Published on 2024-10-16
    9 months ago
  • PET clinical study of novel antipsychotic LB-102 demonstrates unexpectedly prolonged dopamine receptor target engagement
    Published on 2024-10-16
    9 months ago
  • Small-molecule natural product sophoricoside reduces peripheral neuropathic pain via directly blocking of NaV1.6 in dorsal root ganglion nociceptive neurons
    Published on 2024-10-16
    9 months ago
« Previous 1 … 21 22 23 24 25 … 143 Next »
Journal of Psychopharmacology
  • The pseudoscience of lithium and suicide: Reanalysis of a misleading meta-analysis
    Published on 2024-06-12
    1 year ago
  • Esketamine combined with a mindfulness-based intervention for individuals with alcohol problems
    Published on 2024-06-12
    1 year ago
  • Cognitive impairment in schizophrenia is associated with prefrontal–striatal functional hypoconnectivity and striatal dopaminergic abnormalities
    Published on 2024-06-10
    1 year ago
  • The 5-HT1A receptor biased agonists, NLX-204 and NLX-101, like ketamine, elicit rapid-acting antidepressant activity in the rat chronic mild stress model via cortical mechanisms
    Published on 2024-06-03
    1 year ago
  • Tripping into the unknown: Exploring the experiences of first-time LSD users through global drug survey insights
    Published on 2024-05-28
    1 year ago
  • Changes in processing speed during early abstinence from alcohol dependence
    Published on 2024-05-28
    1 year ago
  • Measuring psychotherapeutic processes in the context of psychedelic experiences: Validation of the General Change Mechanisms Questionnaire (GCMQ)
    Published on 2024-05-14
    1 year ago
« Previous 1 … 21 22 23 24 25 … 123 Next »
European Neuropsychopharmacology
  • GLP-1 receptor agonists: A revolution in the treatment of Parkinson’s disease?
    Published on 2024-06-23
    1 year ago
  • Social dysfunction relates to shifts within socioaffective brain systems among Schizophrenia and Alzheimer’s disease patients
    Published on 2024-06-23
    1 year ago
  • Meta-analyses of pharmacogenetics-guided antidepressant treatment: Reply to milosavljevic
    Published on 2024-06-23
    1 year ago
  • Cross-sectional studies: Is pressing the pause button worth it in research?
    Published on 2024-06-23
    1 year ago
  • Does the presence of sleep disorders predict response to TMS in depression?
    Published on 2024-06-23
    1 year ago
  • Psychological symptoms after awake deep brain stimulation surgery in parkinson’s disease, essential tremor, and dystonia
    Published on 2024-06-23
    1 year ago
  • Paid MBP advert_May 37TH_ECNP_CONGRESS_SPEAKERS
    Published on 2024-06-15
    1 year ago
« Previous 1 … 21 22 23 24 25 … 144 Next »

   Pharma Pub